DK1578742T3 - Fremgangsmåde til fremstilling af optisk rene aktive forbindelser - Google Patents

Fremgangsmåde til fremstilling af optisk rene aktive forbindelser

Info

Publication number
DK1578742T3
DK1578742T3 DK03782288.9T DK03782288T DK1578742T3 DK 1578742 T3 DK1578742 T3 DK 1578742T3 DK 03782288 T DK03782288 T DK 03782288T DK 1578742 T3 DK1578742 T3 DK 1578742T3
Authority
DK
Denmark
Prior art keywords
procedure
active compounds
clean active
optically clean
manufacturing optically
Prior art date
Application number
DK03782288.9T
Other languages
English (en)
Inventor
Bernhard Kohl
Bernd Mueller
Ralf Steffen Weingart
Original Assignee
Nycomed Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Gmbh filed Critical Nycomed Gmbh
Application granted granted Critical
Publication of DK1578742T3 publication Critical patent/DK1578742T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Pyrrole Compounds (AREA)
  • Catalysts (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyridine Compounds (AREA)
DK03782288.9T 2002-12-06 2003-12-03 Fremgangsmåde til fremstilling af optisk rene aktive forbindelser DK1578742T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02027273 2002-12-06
DE10340255 2003-08-29
PCT/EP2003/013605 WO2004052882A1 (en) 2002-12-06 2003-12-03 Process for preparing optically pure active compounds

Publications (1)

Publication Number Publication Date
DK1578742T3 true DK1578742T3 (da) 2013-01-21

Family

ID=32509784

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03782288.9T DK1578742T3 (da) 2002-12-06 2003-12-03 Fremgangsmåde til fremstilling af optisk rene aktive forbindelser

Country Status (28)

Country Link
US (1) US7452998B2 (da)
EP (1) EP1578742B1 (da)
JP (1) JP4612542B2 (da)
KR (1) KR101062806B1 (da)
CN (1) CN100482658C (da)
AR (1) AR042277A1 (da)
AU (1) AU2003289948B2 (da)
BR (2) BRPI0310118B1 (da)
CA (1) CA2507807C (da)
CY (1) CY1114058T1 (da)
DK (1) DK1578742T3 (da)
EA (1) EA011771B1 (da)
ES (1) ES2397380T3 (da)
HK (1) HK1078864A1 (da)
HR (1) HRP20050604B1 (da)
IL (1) IL168456A (da)
IS (1) IS2885B (da)
ME (1) ME00563A (da)
MX (1) MXPA05005762A (da)
NO (1) NO330978B1 (da)
NZ (1) NZ540815A (da)
PL (1) PL375818A1 (da)
PT (1) PT1578742E (da)
RS (1) RS52667B (da)
SI (1) SI1578742T1 (da)
TW (1) TWI313268B (da)
WO (1) WO2004052882A1 (da)
ZA (1) ZA200503543B (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1158985B1 (en) 1999-01-13 2011-12-28 Bayer HealthCare LLC OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS
US7301030B2 (en) * 2002-12-06 2007-11-27 Nycomed Gmbh Process for preparing (S)-pantoprazole
FR2848555B1 (fr) * 2002-12-16 2006-07-28 Negma Gild Enantiomere(-)du tenatoprazole et son application en therapeutique
US7507829B2 (en) * 2002-12-19 2009-03-24 Teva Pharmaceuticals Industries, Ltd Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates
MXPA05013316A (es) * 2003-06-10 2006-03-17 Teva Pharma Proceso para preparar bencimidazoles 2[-(piridinil)metil]sulfinil-sustituidos y derivados clorados novedosos de pantoprazol.
BRPI0511515A (pt) * 2004-06-02 2007-12-26 Altana Pharma Ag processo para a preparação de compostos de piridin-2-ilmetilsulfinil-1h-benzimidazol
FR2871800B1 (fr) * 2004-06-17 2006-08-25 Sidem Pharma Sa Sa Sel de sodium monohydrate du s-tenatoprazole et application en therapeutique
KR20130038949A (ko) * 2004-06-24 2013-04-18 아스트라제네카 아베 에소메프라졸 나트륨염의 제조에서 사용하기 위한 결정 변형의 제조를 위한 신규한 방법
EP1801110A1 (en) 2005-12-22 2007-06-27 KRKA, tovarna zdravil, d.d., Novo mesto Esomeprazole arginine salt
US7579476B2 (en) * 2006-02-24 2009-08-25 Praktikatalyst Pharma, Llc Transition metal mediated oxidation of hetero atoms in organic molecules coordinated to transition metals
US8173818B2 (en) 2006-08-08 2012-05-08 Jubilant Organosys Limited Process for producing sulphoxide compounds
US20110009624A9 (en) 2006-10-13 2011-01-13 Masato Ueda Benzimidazole compounds having gastric acid secretion inhibitory action
EP2486910A3 (en) 2006-10-27 2012-08-22 The Curators Of The University Of Missouri Multi-chambered apparatus comprising a dispenser head
EP2265605A4 (en) * 2008-03-18 2011-08-03 Reddys Lab Ltd Dr METHOD OF MANUFACTURING DEXLANSOPRAZOLE AND POLYMORPHIDE THEREOF
EP2143722A1 (en) 2008-07-09 2010-01-13 Lek Pharmaceuticals D.D. Process for preparation of esomeprazole sodium of high chemical purity and new forms of esomeprazole sodium
EP2264024A1 (en) 2008-10-14 2010-12-22 LEK Pharmaceuticals d.d. Process for the preparation of enantiomerically enriched proton pump inhibitors
US8071781B2 (en) 2008-11-11 2011-12-06 Syn-Tech Chem. & Pharm. Co., Ltd. Process for preparing rabeprazole sodium
KR20120114356A (ko) 2010-02-12 2012-10-16 에스티브 퀴미카 에스.에이. 에스오메프라졸 나트륨염의 제조공정
CN103113351B (zh) * 2013-03-08 2015-01-21 苏州特瑞药业有限公司 一种光学纯手性亚砜类化合物的制备方法
CN103936714A (zh) * 2014-04-15 2014-07-23 北京华禧联合科技发展有限公司 一种埃索美拉唑镁的制备方法
EP3239146A4 (en) * 2014-12-26 2018-05-30 The University of Tokyo Method for producing proton pump inhibitor compound having optical activity
CN105440018A (zh) * 2015-11-27 2016-03-30 福州闽海药业有限公司 一种锆催化的右旋兰索拉唑的不对称氧化合成方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
IL75400A (en) 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
JPS6150978A (ja) 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
FI90544C (fi) 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
SE465514B (sv) 1990-02-19 1991-09-23 Curt Pettersson Foerfarande och anvaendning av ett separationsmedium vid separation av enantiomerer
DE4035455A1 (de) 1990-11-08 1992-05-14 Byk Gulden Lomberg Chem Fab Enantiomerentrennung
AU6713194A (en) 1993-04-27 1994-11-21 Sepracor, Inc. Methods and compositions for treating gastric disorders using optically pure (-) pantoprazole
WO1994025028A1 (en) 1993-04-27 1994-11-10 Sepracor, Inc. Methods and compositions for treating gastric disorders using optically pure (+) pantoprazole
SE9301830D0 (sv) 1993-05-28 1993-05-28 Ab Astra New compounds
SE504459C2 (sv) 1994-07-15 1997-02-17 Astra Ab Förfarande för framställning av substituerade sulfoxider
GB9423970D0 (en) 1994-11-28 1995-01-11 Astra Ab Oxidation
GB9423968D0 (en) 1994-11-28 1995-01-11 Astra Ab Resolution
HRP960232A2 (en) 1995-07-03 1998-02-28 Astra Ab A process for the optical purification of compounds
US7301030B2 (en) * 2002-12-06 2007-11-27 Nycomed Gmbh Process for preparing (S)-pantoprazole

Also Published As

Publication number Publication date
EP1578742B1 (en) 2012-10-17
IS7909A (is) 2005-06-23
CN100482658C (zh) 2009-04-29
KR101062806B1 (ko) 2011-09-07
NO20053099D0 (no) 2005-06-24
IS2885B (is) 2014-07-15
IL168456A (en) 2012-02-29
AU2003289948A1 (en) 2004-06-30
CA2507807A1 (en) 2004-06-24
WO2004052882A1 (en) 2004-06-24
EA011771B1 (ru) 2009-06-30
TW200508219A (en) 2005-03-01
ES2397380T3 (es) 2013-03-06
NZ540815A (en) 2008-03-28
BR0317005A (pt) 2005-10-25
HRP20050604A2 (en) 2006-09-30
JP4612542B2 (ja) 2011-01-12
US20050288334A1 (en) 2005-12-29
AU2003289948B2 (en) 2009-12-24
EA200500898A1 (ru) 2005-12-29
ZA200503543B (en) 2006-08-30
ME00563A (en) 2011-12-20
JP2006516261A (ja) 2006-06-29
CY1114058T1 (el) 2016-07-27
KR20050085224A (ko) 2005-08-29
PT1578742E (pt) 2013-01-24
HK1078864A1 (en) 2006-03-24
RS20050423A (en) 2007-04-10
NO330978B1 (no) 2011-08-29
HRP20050604B1 (hr) 2013-09-30
EP1578742A1 (en) 2005-09-28
NO20053099L (no) 2005-06-24
SI1578742T1 (sl) 2013-02-28
BRPI0310118B1 (pt) 2015-10-20
PL375818A1 (en) 2005-12-12
MXPA05005762A (es) 2005-08-16
US7452998B2 (en) 2008-11-18
RS52667B (en) 2013-06-28
TWI313268B (en) 2009-08-11
AR042277A1 (es) 2005-06-15
CN1717403A (zh) 2006-01-04
CA2507807C (en) 2013-10-22

Similar Documents

Publication Publication Date Title
DK1578742T3 (da) Fremgangsmåde til fremstilling af optisk rene aktive forbindelser
DE60312557D1 (de) Ein optisches filter
IS7706A (is) Gerviaugasteinn
DK1504126T3 (da) Fremgangsmåde til regulering af genekspression
IS7471A (is) Ný efnasambönd
IS7879A (is) Ný efnasambönd
DK1503984T3 (da) 8-azaprostaglandin-analoger som midler til sænkning af intraokulært tryk
ATE368042T1 (de) Cephemverbindungen
NO20054310D0 (no) Polyetylenglykolbundede GLP-1-forbindelser
DE60318905D1 (de) Optisches Element
DK1997512T3 (da) Fremgangsmåder til behandling af TWEAK-relaterede tilstande
DK1611108T3 (da) Fremgangsmåde til fremstilling af telmisartan
DK1610878T3 (da) Fremgangsmåde til fremstilling af partikler
IS7414A (is) Oxó-azabísýklísk efnasambönd
DK1567493T3 (da) Phenyl-substituerede piperidin-forbindelser til anvendelse som PPAR-aktivatorer
DK1657996T3 (da) Fremgangsmåde til fremstilling af en madraskerne
DK1600441T3 (da) Krystallinsk form af elrcanidipinhydrochlorid til anvendelse som et antihypertensivt middel
NO20045659L (no) Forbindelser
DK1457589T3 (da) Fremgangsmåde til rengöring af spindeindretninger
NO20055097D0 (no) Krystallinske N-formyl-hydroksylaminforbindelser
DE60217410D1 (de) Optisches element
ITMI20020161A0 (it) Filtro attivo
DK1503995T3 (da) Fremgangsmåde til fremstilling af substituerede phenylsulfonylurinstoffer
DK1574493T3 (da) Fremgangsmåde til fremstilling af anthracendiether
DE50312374D1 (de) Einbauleuchte